Regencell Bioscience Stock (NASDAQ:RGC)
Previous Close
$15.29
52W Range
$0.08 - $83.60
50D Avg
$17.76
200D Avg
$4.66
Market Cap
$7.35B
Avg Vol (3M)
$3.01M
Beta
2.62
Div Yield
-
RGC Company Profile
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.